MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific challenges Nevro patent

Boston Scientific challenges Nevro patent

By

Boston Scientific challenges Nevro patent

Nevro Corp. (NYSE:NVRO) yesterday vowed to "vigorously defend" 1 of its patents against a pair of challenges from Boston Scientific (NYSE:BSX).

Nevro’s Senza device, which won pre-market approval from the FDA last week, is designed to deliver up to 10,000Hz to the spinal cord, allowing it to avoid the tingling sensation known as paresthesia that bothers some patients.

The FDA is allowing the company to label the device as superior to other spinal cord stimulators, including some made by Boston Scientific.

Marlborough, Mass.-based Boston apparently wants to cut into that edge a bit, filing a pair of inter partes review petitions with the U.S. Patent & Trademark Office’s Patent Trial & Appeals Board to challenge the validity of the Nevro patent.

The patent, no. 8,359,102, covers "Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods," according to the PTO.

"The ‘102 patent is 1 of Nevro’s 52 issued U.S. patents directed to Nevro’s innovations in the neuromodulation field. Nevro intends to vigorously defend its intellectual property in this matter," the company said in a press release.

In case you missed it

RSS From Medical Design & Outsourcing

  • Evonik invests in Revivo BioSystems and its compound-testing technology
    Evonik announced that it invested in startup Revivo BioSystems to support the development and commercialization of its technology. Essen, Germany-based Evonik said in a news release that Revivo BioSystems develops technology that uses a realistic 4D model of human skin to test chemical, cosmetic and pharmaceutical compounds, offering an alternative to animal testing that can… […]
  • Fresenius Medical Care earns ‘B’ rating for climate protection measures
    Fresenius Medical Care announced today that it received a positive rating for its efforts in climate protection. According to a news release, the company garnered a “B” rating from the nonprofit organization CDP, marking its place in the second-highest categories. Fresenius said it received a “B” in the climate area and a “B–” in the water area. The… […]
  • Artio Medical to build manufacturing facilities in Kansas
    Artio Medical today announced that it received the green light to build commercial manufacturing operations in Kansas. The city council in Olathe, Kansas approved a development agreement that granted land to Prairie Village, Kansas-based Artio Medical to build two commercial manufacturing buildings. The company plans to build an initial 50,000+ sq. ft facility on the 18-acre… […]
  • Integrated Computer Solutions, Variscite to collaborate on hardware and software solution
    Integrated Computer Solutions (ICS) and Variscite announced today that they are collaborating on new solutions in the embedded market. The collaboration aims to offer a complete hardware and software solution to customers in the market, with Variscite’s SoM (system on module) solutions and ICS’ best-in-class software services set to provide a complete system solution that… […]
  • Veranex acquires medtech design firm Worrell
    Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount. Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach. “The addition of Worrell strengthens… […]
  • Movia Robotics launches TheraPal digital health aide for neurodiverse individuals
    Movia Robotics this week announced that it has launched its TheraPal line of digital health aides for autism spectrum disorder and other intellectual or developmental disabilities. Bristol, Connecticut-based Movia Robotics released its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assist aides for use in homes and clinician offices. The robotic aides are designed to… […]
  • Instron launches Bluehill Central lab management software
    Instron announced today that it launched the Bluehill Central lab management solution for Bluehill Universal software. Norwood, Massachusetts-based Instron’s Bluehill Central platform allows lab managers to remotely manage all test systems running Bluehill Universal, regardless of the number of systems and regardless of their location around the world, according to a news release. The company… […]
  • Lenovo, LG to collaborate on radiology technology
    Lenovo and LG announced today that they are collaborating on new medical imaging solutions to aid the radiology community. According to a news release, the companies will work together to bundle LG’s high-performance medical monitors with the Lenovo original equipment manufacturer (OEM) solutions commercial third-party portfolio of offerings. Get the full story at our sister… […]
  • Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
    Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with… […]
  • HHS reports 63-fold increase in telehealth use during pandemic
    A new study from the U.S. Department of Health and Human Services found a 63-fold increase in Medicare telehealth use during the COVID-19 pandemic. The report analyzed Medicare fee-for-service data from 2019 and 2020 and highlighted that people in urban areas were more likely to seek and use telehealth services than rural residents. In addition,… […]
  • Carlyle makes a significant investment in Resonetics
    Carlyle-managed funds have acquired a significant interest in medical device contract manufacturer Resonetics. Today’s announcement did not include the investment size, but the deal values Nashua, New Hampshire–based Resonetics at roughly  $2.25 billion. Carlyle joins existing investor GTCR as a meaningful shareholder in the company. Resonetics focuses on producing highly technical components for medical device… […]

Leave a Reply